A Repeat-dose, Open-label, Randomized, Incomplete Block Design in Pediatric Subjects With Asthma, Ages 4 - 11 Years, to Compare Systemic Exposure and Pharmacodynamics of Fluticasone Propionate and Salmeterol Following Advair HFA 45/21mcg (2 Inhalations), ADVAIR HFA 45/21mcg (2 Inhalations) With Aerochamber Plus Spacer and Advair Diskus 100/50 Twice Daily
Phase of Trial: Phase IV
Latest Information Update: 05 Aug 2016
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 24 Mar 2009 Actual initiation date changed from Nov 2006 to Oct 2006 as reported by ClinicalTrials.gov.
- 24 Mar 2009 Actual end date changed from Jul 2007 to Feb 2007 as reported by ClinicalTrials.gov.
- 29 Oct 2007 Status changed from in progress to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History